UNSPSC 51183614: Insulin human

This classification denotes a therapeutic insulin with the molecular formula C257H383N65O77S6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 1Y17CTI5SR, chemically known as insulin (ox), 8a-l-threonine-10a-l-isoleucine-30b-l-threonine- but more generally known as insulin, which bears US NIH Compound Identifier 16129672. European Medicines Agency schedules Insulin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02689MIG.

UNSPSC 51183614 Insulin human is a Commodity code covering human insulin products procured by state and local health systems, correctional facilities, and public health agencies. State and local governments buy human insulin to stock pharmacy inventories, support inpatient and outpatient diabetes care, and meet formulary obligations in detention settings. The product category spans multiple insulin formulations and delivery mechanisms—including rapid-acting, short-acting, intermediate-acting, and long-acting preparations—though recent state and local solicitations do not distinguish between specific types or manufacturers in publicly available opportunity records. Issuing bodies include state departments of health and human services, county health departments, municipal health clinics, state prison systems, and regional public health authorities responsible for uninsured and underinsured populations.

The source provides no recent state and local contract opportunities tagged to UNSPSC 51183614. Without posted RFPs, RFQs, IFBs, or ITBs naming this code, geographic spread and current procurement activity cannot be determined from available records. Human insulin procurement does occur across state and local systems nationwide, but the absence of recent public solicitations under this specific code suggests that many jurisdictions procure insulin through cooperative purchasing vehicles, standing orders with group purchasing organizations, or pharmaceutical supply agreements that may use broader health-product codes rather than this commodity-level identifier.